Withdrawal symptoms after discontinuation of transdermal scopolamine therapy: Treatment with meclizine-Reference-Cited by-同舟云学术

Withdrawal symptoms after discontinuation of transdermal scopolamine therapy: Treatment with meclizine

Published:2009-11-15 Issue:22 Volume:66 Page:2024-2026
ISSN:1079-2082
Container-title:American Journal of Health-System Pharmacy
language:en
Short-container-title:

Author:

Patel Priti N.¹,Ezzo Danielle C.²

Affiliation:

1. Drug Information Center, College of Pharmacy and Allied Health Professions, St. John’s University, Queens, NY

2. College of Pharmacy and Allied Health Professions, St. John’s University, and Clinical Coordinator of Ambulatory Care, Long Island Jewish Medical Center, New Hyde Park, NY

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Link

http://academic.oup.com/ajhp/article-pdf/66/22/2024/28314663/ajhp2024.pdf

Reference13 articles.

1. A method for estimating the probability of adverse drug reactions

2. Transdermal Scopolamine Withdrawal Syndrome

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hyoscine patch withdrawal syndrome in a returned traveller;Emergency Medicine Australasia;2020-09-22

2. Acupuncture Relieves Motion Sickness via the Irβ-Erk1/2-Dependent Insulin Receptor Signalling Pathway;Acupuncture in Medicine;2018-06

3. Transdermal Scopolamine Withdrawal Syndrome Case Report in the Pediatric Cerebral Palsy Population;American Journal of Physical Medicine & Rehabilitation;2017-08

4. Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse;Pharmacological Reviews;2015-09-24

5. Unique Scopolamine Withdrawal Syndrome After Standard Transdermal Use;Clinical Neuropharmacology;2015-09